A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn’s Disease

This study has been completed.

Study NCT00078611 Information provided by Elan Pharmaceuticals

First Received: March 1, 2004 Last Updated: October 26, 2005 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given